[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338970-105":59,"doc-detail-338970-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-pan-carcinoma-analysis-of-itgb1-distortion-and-its-potential-clinical-significance-for-cancer-immunity-abstract","Comprehensive pan-carcinoma analysis of ITGB1 distortion and its potential clinical significance for cancer immunity - Abstract","","The human gene ITGB1 (Integrin 1/CD29) encodes a major integrin subunit involved in multiple intracellular signaling pathways. Its roles across malignancies are insufficiently understood, and the links between ITGB1 and cancer onset and progression remain unclear. This study evaluates ITGB1 in 33 human cancers and finds significant expression alterations in tumor tissues for three malignancies. Survival analyses identify ITGB1 as an independent prognostic factor in several cancers, and its expression correlates with immune infiltration, proliferation, and EMT, supporting further investigation of its oncogenic and immunotherapy relevance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-pan-carcinoma-analysis-of-itgb1-distortion-and-its-potential-clinical-significance-for-cancer-immunity-abstract/338970/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-pan-carcinoma-analysis-of-itgb1-distortion-and-its-potential-clinical-significance-for-cancer-immunity-abstract/338970.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is ITGB1 and why is it important in cancer research?","Question",{"text":112,"@type":113},"ITGB1 (Integrin 1/CD29) is a major integrin subunit participating in many intracellular signaling pathways. The study targets its cancer-related functions and clinical relevance across multiple malignancies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many cancers and which datasets were analyzed?",{"text":117,"@type":113},"The analysis covers 33 human cancers. Data were collected from TCGA and GTEx for pan-cancer expression comparisons, and additional tools were used for expression and survival assessments.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationships did the study find between ITGB1 expression and clinical outcomes or tumor biology?",{"text":121,"@type":113},"Multi-platform analysis shows significant ITGB1 expression changes in tumor tissues for three cancers compared with normal tissues. Survival analysis indicates ITGB1 as an independent prognostic factor in several cancers, and ITGB1 correlates with immune infiltration, proliferation, and EMT indicators, suggesting roles in metastasis and growth.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338970,1790420184,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Research  \nComprehensive pan‑carcinoma analysis of ITGB1 distortion and its potential clinical significance for cancer immunity  \nYuchang Fei1 · Yulun Wu2 · Luting Chen3 · HuanYu4 · Lei Pan5  \nReceived: 2 September 2023 / Accepted: 20 February 2024  \n© The Author(s) 2024 OPEN  \nAbstract  \nThe human protein-coding gene ITGB1 (Integrin 1), also known as CD29, has a length of 58048 base pairs. The Integrin family’s most prevalent subunit, it participates in the transmission of numerous intracellular signaling pathways. A thorough examination of ITGB1’s functions in human malignancies, however, is inadequate and many of their relationships to the onset and development of human cancers remain unknown. In this work, we examined ITGB1’s role in 33 human cancers. Finally, a multi-platform analysis revealed that three of the 33 malignancies had significantly altered ITGB1 expression in tumor tissues in comparison to normal tissues. In addition, it was discovered through survival analysis that ITGB1 was a stand-alone prognostic factor in a number of cancers. ITGB1 expression was linked to immune cell infiltration in colon cancer, according to an investigation of immune infiltration in pan-cancer. In the gene co-expression research, ITGB1 showed a positive connection with the majority of the cell proliferation and EMT indicators, indicating that ITGB1 may have an essential function in controlling cancer metastasis and proliferation. Our pan-cancer analysis of ITGB1 gives evidence in favor of a further investigation into its oncogenic function in various cancer types.  \nKeywords ITGB1 · Pan-cancer · Bioinformatics · Immunity · Prognostic  \n1 Introduction  \nCancer, as a serious public unhealthiness worldwide, remains the second leading reason behind death worldwide and a major barrier to increasing expectancy [1]. The number of cancer cases worldwide is predicted to rise by 47 percent by 2040 to 28.4 million cases [2]. Due to its biological complexity and heterogeneity, and driven by environmental selective forces, cancer undergoes alterations in DNA methylation, histone, and transcriptome levels, which in turn trigger tumor progression [3], and existing biomarkers have limitations in predicting cancer prognosis. Moreover, the same gene may play different roles in different types of cancer. Pan-cancer analysis of cancer-associated genes to explore new biomarkers as prognostic and efficacy indicators for immunotherapy can better guide clinical work.  \nITGB1, a subunit of the heterodimeric transmembrane receptor, is formed by binding to the ITGA subunit or the corresponding ligand [4] and is a member of the integrin-β (ITGB) superfamily, which is important in biological processes  \n* Yuchang Fei, [feiyuchang123456@163.com |](feiyuchang123456@163.com |1Department of)[1](feiyuchang123456@163.com |1Department of)[Department of](feiyuchang123456@163.com |1Department of) Integrated Chinese and Western Medicine, The First People’s Hospital of Jiashan, Jiashan Hospital Affiliated of Jiaxing University, Jiashan, Zhejiang, China. 2Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China. 3Department of Integrated Chinese and Western Medicine, The First People’s Hospital of Wenling, Wenling, Zhejiang, China. 4The Department of Traditional Chinese Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China. 5Department of Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.  \nDiscover Oncology  \n(2024) 15:47  \n| [https://doi.org/10.1007/s12672-024-00901-9](https://doi.org/10.1007/s12672-024-00901-9)  \nsuch as cell proliferation, carcinogenesis, and immune response [5] . It was found that overexpression of ITGB1 was significantly associated with advanced AJCC stage,","cbCaieeS5ZIcasch","https://ap.wps.com/l/cbCaieeS5ZIcasch","pdf",4800867,17,"English","# Abstract\n# 1 Introduction\n# 2 Materials and methods\n## 2.1 Data collection and standardization criteria\n## 2.2 ITGB1 expression analysis and survival analysis","[{\"question\":\"What is ITGB1 and why is it important in cancer research?\",\"answer\":\"ITGB1 (Integrin 1/CD29) is a major integrin subunit participating in many intracellular signaling pathways. The study targets its cancer-related functions and clinical relevance across multiple malignancies.\"},{\"question\":\"How many cancers and which datasets were analyzed?\",\"answer\":\"The analysis covers 33 human cancers. Data were collected from TCGA and GTEx for pan-cancer expression comparisons, and additional tools were used for expression and survival assessments.\"},{\"question\":\"What relationships did the study find between ITGB1 expression and clinical outcomes or tumor biology?\",\"answer\":\"Multi-platform analysis shows significant ITGB1 expression changes in tumor tissues for three cancers compared with normal tissues. Survival analysis indicates ITGB1 as an independent prognostic factor in several cancers, and ITGB1 correlates with immune infiltration, proliferation, and EMT indicators, suggesting roles in metastasis and growth.\"}]","Comprehensive pan-carcinoma analysis of ITGB1 distortion and its potential clinical significance for cancer immunity - Abstract | PDF",1790026902,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e49a3da7f402424997709dd2d15f8949.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/362e9323a4456c7dd1bdf72e427cc4cd.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18c2c1dda0cf17c77fa2de31ac877bf1.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60706ed6c3ec6f951010126df9e72768.webp",980,1301]